All 1 tracked stories fall under one category: regulation. Centers for Disease Control and Prevention (CDC) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Human Tissue Act
All 1 tracked stories fall under one category: regulation. Centers for Disease Control and Prevention (CDC) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. The 5 average consequence score is below the beat benchmark of 5.9 in the same window. We currently track 1 Healthcare story that mention Human Tissue Act, all published on March 4, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Human Tissue Act. Shared-story counts are live from our verified record — not editorial picks.
The growing trend of patients requesting to keep biological remains—from placentas for consumption to surgical bone for jewelry—is creating significant clinical and regulatory challenges. Medical experts warn that these practices carry substantial risks of infection and cross-contamination, necessitating clearer institutional policies.